Navigation Links
Pharsight to Present at B. Riley & Co. 9th Annual Las Vegas Investor Conference
Date:3/26/2008

MOUNTAIN VIEW, Calif., March 26 /PRNewswire-FirstCall/ -- Pharsight Corporation (Nasdaq: PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development announced today that it will be presenting at B. Riley & Co. 9th Annual Las Vegas Investor Conference on April 2, 2008 at the Palms Las Vegas. Shawn O'Connor, Pharsight's President and CEO, and William Frederick, Senior Vice President and CFO, will be presenting on April 2nd, at 1:30 p.m. PT.

Attendance at the conference is by invitation only. A live audio webcast of the presentation with slides will be broadcast via the Internet. The webcast can be viewed at the company's website under the investor relations section at http://www.pharsight.com.

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. Pharsight's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com


'/>"/>
SOURCE Pharsight Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics
2. Pharsights Reporting and Analysis Services Business Unit to Leverage New Validated Data Management System
3. Pharsight Welcomes Newest Japanese PKS, AutoPilot Customer
4. Pharsight to Present at Jesup and Lamont 2008 Emerging Growth Stock Conference
5. Pharsight Achieves $7.4 Million in Quarterly Revenue
6. Pharsight Announces Fiscal Third Quarter 2008 Earnings Release Date and Conference Call
7. Pharsights Reporting and Analysis Services Business Reaches Quality Assurance Milestone
8. Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer
9. Pharsight Announces 1-For-3 Reverse Stock Split
10. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
11. Pharsight Invited to Present on Winning Strategies for R&D Productivity at New York Pharma Forum on October 15, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... of a United States multicenter, prospective clinical study that demonstrates the accuracy ... test capable of identifying clinically significant acute bacterial and viral respiratory tract ...
(Date:10/11/2017)... ... October 11, 2017 , ... At its national board ... Suneel I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based Advanced ... for membership in ARCS Alumni Hall of Fame . ASTER Labs is ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ... hosting a Webinar titled, “Pathology is going digital. Is your lab ready?” with ... adoption best practices and how Proscia improves lab economics and realizes an increase ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... the implantation and pregnancy rates in frozen and fresh in vitro fertilization ... progesterone and maternal age to IVF success. , After comparing the results from ...
Breaking Biology Technology:
(Date:8/15/2017)... HAMPTON, Va. , Aug. 15 2017   ivWatch LLC ... effectiveness of intravenous (IV) therapy, today announced receipt of its ISO ... (QMS) developed by the International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for ... "This ...
(Date:5/23/2017)... the first robotic gym for the rehabilitation and functional motor sense evaluation ... Genoa, Italy . The first 30 robots will be available from ... . The technology was developed and patented at the IIT laboratories ... Technology thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
Breaking Biology News(10 mins):